These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23903569)

  • 1. Pathway for approval of a gene therapy orphan product: treading new ground.
    Byrne BJ
    Mol Ther; 2013 Aug; 21(8):1465-6. PubMed ID: 23903569
    [No Abstract]   [Full Text] [Related]  

  • 2. Orphan products: an emerging trend in drug approvals.
    Coté T; Kelkar A; Xu K; Braun MM; Phillips MI
    Nat Rev Drug Discov; 2010 Jan; 9(1):84. PubMed ID: 20043031
    [No Abstract]   [Full Text] [Related]  

  • 3. Orphan Drug Designation and Exclusivity for "Same Drugs".
    Hong P; Sarpatwari A; Kesselheim AS
    J Law Med Ethics; 2019 Jun; 47(2):347-349. PubMed ID: 31298092
    [No Abstract]   [Full Text] [Related]  

  • 4. Orphan drugs.
    Novack GD
    Ocul Surf; 2008 Jan; 6(1):52-3. PubMed ID: 18264655
    [No Abstract]   [Full Text] [Related]  

  • 5. The routes to orphan drug designation--our recent experience at the FDA.
    Lev D; Thorat C; Phillips I; Thomas M; Imoisili MA
    Drug Discov Today; 2012 Feb; 17(3-4):97-9. PubMed ID: 22210120
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
    Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
    Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Orphan Drug Act Revisited.
    Thomas S; Caplan A
    JAMA; 2019 Mar; 321(9):833-834. PubMed ID: 30768155
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulators adopt more orphan drugs.
    Reardon S
    Nature; 2014 Apr; 508(7494):16-7. PubMed ID: 24695293
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental use and the Orphan Drug Act: a biotechnology conundrum.
    Koivuniemi PJ
    Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930
    [No Abstract]   [Full Text] [Related]  

  • 10. The Orphan Drug Act: an engine of innovation? At what cost?
    Rohde DD
    Food Drug Law J; 2000; 55(1):125-43. PubMed ID: 12322720
    [No Abstract]   [Full Text] [Related]  

  • 11. A personal perspective of orphan drug development for rare diseases: A golden opportunity or an unsustainable future?
    Oo C; Rusch LM
    J Clin Pharmacol; 2016 Mar; 56(3):257-9. PubMed ID: 26211513
    [No Abstract]   [Full Text] [Related]  

  • 12. Hints on preparing successful orphan drug designation requests.
    Buday PV
    Food Drug Law J; 1996; 51(1):75-84. PubMed ID: 11794354
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoption agents.
    Wapner J
    Sci Am; 2010 Jun; 302(6):19-20. PubMed ID: 20521471
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years.
    Braun MM; Farag-El-Massah S; Xu K; Coté TR
    Nat Rev Drug Discov; 2010 Jul; 9(7):519-22. PubMed ID: 20531273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States.
    Nakayama H; Matsumaru N; Tsukamoto K
    Invest New Drugs; 2019 Oct; 37(5):1086-1093. PubMed ID: 29855823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the Purpose of the Orphan Drug Act?
    Herder M
    PLoS Med; 2017 Jan; 14(1):e1002191. PubMed ID: 28045908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare-disease drugs to receive consideration on par with serious-disease drugs.
    Thompson CA
    Am J Health Syst Pharm; 2012 Nov; 69(22):1936-7. PubMed ID: 23135552
    [No Abstract]   [Full Text] [Related]  

  • 18. Rare diseases, orphan drugs, and orphaned patients.
    Scheindlin S
    Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
    [No Abstract]   [Full Text] [Related]  

  • 19. Berlex continues legal challenge to FDA over MS drug.
    Glaser V
    Nat Biotechnol; 1996 Jul; 14(7):811-2. PubMed ID: 9630997
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology and orphan drugs: an informational inventory 2006-2010.
    Bashaw ED; Fang L
    Clin Pharmacol Ther; 2012 May; 91(5):932-6. PubMed ID: 22453190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.